Top Epidemic Disease Rapid Test Products

Hotgen creates quick, accurate, and reasonably priced rapid tests including dengue fever rapid test kits, influenza A and B test kits, and Covid-19 test kit colloidal cold, monkeypox test kits. Whenever there is an epidemic, these superior diagnostic products are chosen by our partners, medical workers, and even individuals. Sound quality and reputation has made Hotgen brand one of the favorite in more than 30 nations in 4 continents, including China, Germany, the United Kingdom, and Brazil. Hotgen's 20-million-tests daily production capacity proves its resiliency across various epidemics and incidents, and is well trusted by our partners around the world.

 

Advantages of Hotgen's Epidemic Infectious Disease Test Kits

Quick: Quickly display results within 15 minutes with sound accuracy

Precision: With the highest levels in both precision and specificity

Easy Operations: No requirement of complicated instruments Resilient to environmental factors Supports a variety of sample types, such as nasopharyngeal swabs, throat swabs, blood and serum

 

What Are Hotgen's Epidemic Disease Rapid Test Products Uses?

In face of epidemics, Hotgen’s epidemic rapid test solutions are widely adopted in countries around the world by both public and private entities. These fast, accurate and convenient tests are widely used in various scenarios that require efficient virus screening or diagnostics to control epidemic, such as emergency screening in medical institutions, entry testing at border controls, and mass screening in communities and schools.

 

Hotgen’s rapid epidemic rapid tests now cover diseases like COVID-19, monkeypox, dengue fever and influenza A/B. Whenever there is an epidemic, these superior diagnostic products are chosen by our partners, medical workers, and even individuals.

 

Now the price of disease test kit is reasonable. If you want to buy disease kit, please contact us.

 

Enjoyed this article? Stay informed by joining our newsletter!

Comments

You must be logged in to post a comment.

About Author

Beijing Hotgen Biotech Co., Ltd. (SSE Code: 688068) ("Hotgen") is a biotechnology company in Beijing, focusing on in-vitro diagnosis (IVD) and antibody medicines. Founded in 2005, Hotgen takes up a mission of “Developing biotechnology, Benefiting human health”, formulating 8 IVD technology platforms for research and manufacturing, covering over 30 countries. The company became the first IVD company listed on China’s STAR Board in 2019, and achieved a sales of CNY3.6 billion in 2022.Hotgen develops over 100 diagnostic parameters involving cardiac, liver diseases, inflammation, drug abuse, and etc, which can be categorized into 4 sections, i.e. mono-test chemiluminescence platform, up-converting phosphorus technology (UPT) platform, and colloidal gold rapid tests and enzyme-linked immunoassay tests. https://www.hotgenbiotech.com/